posted on 2023-04-03, 22:00authored byKayla J. Steinberger, Michael T. Bailey, Amy C. Gross, Laura A. Sumner, Jeffrey L. Voorhees, Nisha Crouser, Jennifer M. Curry, Yijie Wang, A. Courtney DeVries, Clay B. Marsh, Ronald Glaser, Eric V. Yang, Timothy D. Eubank
Neither norepinephrine nor recombinant CCL2 have proliferative effects on B16F10 cells.
Funding
NCI
NHLBI
Gilbert and Kathryn Mitchell Endowment
Research Investment Fund
OSU College of Medicine
OSU Comprehensive Cancer Center Core
History
ARTICLE ABSTRACT
Psychological stressors have been implicated in the progression of various tumor types. We investigated a role for stress in tumor immune cell chemotaxis in the B16F10 mouse model of malignant melanoma. We exposed female mice to 6-hour periods of restraint stress (RST) for 7 days, then implanted B16F10 malignant melanoma tumor cells and continued the RST paradigm for 14 additional days. We determined serum corticosterone and liver catecholamine concentrations in these mice. To evaluate the tumor microenvironment, we performed IHC and examined cytokine expression profiles using ELISA-based analysis of tumor homogenates. We found that tumors in mice subjected to RST grew significantly slower, had reduced tumor C-C motif ligand 2 (CCL2), and contained fewer F4/80-positive macrophages than tumors from unstressed mice. We observed a concomitant increase in norepinephrine among the RST mice. An in vitro assay confirmed that norepinephrine downregulates CCL2 production in both mouse and human macrophages, and that pretreatment with the pan-β-adrenergic receptor inhibitor nadolol rescues this activity. Furthermore, RST had no effect on tumor growth in transgenic CCL2-deficient mice. This study suggests that stress reduces malignant melanoma by reducing recruitment of tumor-promoting macrophages by CCL2.